Home > News & Resources > News > 2005 > September > Study looking at combination treatment for 12 weeks versus 24 weeks in HCV Genotype 2 or 3
Study looking at combination treatment for 12 weeks versus 24 weeks in HCV Genotype 2 or 3
Posted: 22-Sep-2005 << BACK
To read the original abstract Click Here
